Business Updates
Burjeel celebrates London listing of $500 million Sukuk after strong investor demand
Healthcare group marks admission of its debut Sukuk to the London Stock Exchange's International Securities Market after attracting a $1.6 billion orderbook.
Burjeel Holdings marked the admission of its inaugural $500 million Sukuk to trading on the London Stock Exchange's International Securities Market (ISM) with a Market Open Ceremony, following strong demand from regional and international investors.
The listing follows the successful completion of Burjeel's debut Sukuk issuance under its $1.5 billion Senior Unsecured Sukuk Programme, marking the healthcare group's first entry into international debt capital markets and the first Sukuk issued by a MENA healthcare provider since 2018.
The ceremony was attended by Sheikh Khalid bin Saud Al Qasimi, Deputy Chief of Mission at the UAE Embassy in the UK, Dr Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, senior company executives and representatives of the London Stock Exchange.
The proceeds from the Sukuk will be used to refinance existing debt while supporting Burjeel's long-term growth strategy, including investments in advanced clinical care, medical research, education, digital transformation and artificial intelligence-enabled healthcare.
"Today's ceremony marks an important chapter in Burjeel Holdings' journey. It reflects how far we have come as an organisation and reinforces our commitment to building a healthcare platform that combines clinical excellence with long-term financial strength," he said.
Burjeel said the successful issuance strengthens its financial platform as it continues expanding specialised healthcare services across the region.
Founded in 2007, Burjeel Holdings operates an integrated healthcare network of 89 assets across the UAE, Oman and Saudi Arabia, including 20 hospitals, 41 medical centres, two physiotherapy centres, 15 pharmacies and 11 allied healthcare businesses.
The group said the capital raised will help support its ambition to invest in next-generation healthcare while expanding access to specialised medical services across the GCC.
Dubai Investments to take full ownership of Clemenceau Medical Center Dubai in non-cash deal
Aster DM Healthcare has acquired a majority stake in ProCare Hospital in Saudi Arabia’s Eastern Province through a joint venture with Abdulrahman Saleh Al Rajhi and Partners Co Group.
As part of this investment, the facility has been rebranded as Aster ProCare Hospital. The company plans to double the hospital’s current capacity, increasing its licensed bed count from 100 to 209. This expansion also includes the introduction of new medical specialties, the integration of advanced healthcare technologies, and the implementation of Aster's established clinical governance framework.
The acquisition will expand ProCare’s licensed bed capacity from 100 to 209 beds, with additional specialities and advanced medical technologies. Founded in 2009, the multi-speciality hospital will adopt Aster’s clinical governance standards and digital health solutions. The expansion brings Aster’s total bed count in Saudi Arabia above 500 beds.
GlobeMed Gulf and Mubadala Health Dubai sign strategic cooperation agreement to enhance healthcare access for insured members
GlobeMed Gulf and Mubadala Health Dubai have signed a strategic partnership to expand healthcare access and improve the patient experience across Dubai. By connecting GlobeMed’s extensive regional network of insurers, employers, and insured members to Mubadala Health Dubai's advanced, multidisciplinary ecosystem—part of M42—the agreement grants eligible members seamless access to a comprehensive suite of services, ranging from diagnostics and day surgery to pediatrics and rehabilitation.
Highlighting the significance of the collaboration, GlobeMed Gulf CEO Nada Majdalani noted that the partnership directly advances their mission to provide insured members with preventive, personalized care that drives superior health outcomes and strengthens communities across the region.
M42’s national lab partners with Abbott to bring early cancer detection to the UAE
M42's National Reference Laboratory (NRL) has signed a partnership with Abbott to introduce early cancer detection technology in the UAE. The collaboration centers on advanced diagnostic tools that use biomarker testing and multi-marker algorithm-driven analysis to identify cancer at its earliest stages, when treatment is most likely to succeed.
Early cancer detection is one of the biggest challenges in modern healthcare. Most cancers are far easier to treat when caught early, yet many cases are still diagnosed late because current screening methods are either too invasive, too expensive, or simply not widely available. This partnership is a direct attempt to change that in the UAE.
Fakeeh Care Group expands presence in Riyadh with the acquisition of Dr. Mohammad Rashid Al Fagih Hospital
Fakeeh Care Group has completed the acquisition of Dr. Mohammad Bin Rashid Al Fagih Hospital in Riyadh, boosting its capacity with a 350-bed facility that nearly triples its local footprint to 535 beds and brings its total kingdom-wide capacity to 1,185 beds.
The transaction significantly expands the group's presence in the capital by adding 12 operating rooms and an independent 192-clinic outpatient building, ultimately diversifying its patient and payer mix while strengthening operational synergies across its healthcare network in Saudi Arabia.
On this occasion, Dr. Mazen Fakeeh, Chairman of Fakeeh Care Group, stated:
“This acquisition marks a new strategic milestone in the Group’s growth journey and reflects our commitment to continuously investing in the development of the Kingdom’s healthcare system. We look forward to leveraging the exceptional capabilities of
Dr. Mohammad Al Fagih Hospital to enhance service integration, broaden our patient reach, and deliver comprehensive healthcare adhering to the highest quality standards, in line with the objectives of Saudi Vision 2030.”
Abu Dhabi Biobank and Bascom Palmer Eye Institute partner to establish the Middle East's first Eye Bank in Abu Dhabi
Abu Dhabi Biobank (ADBB), a strategic initiative between the Department of Health - Abu Dhabi, the regulator of the healthcare sector in the Emirate, and M42, a global health leader, announced a landmark collaboration with Bascom Palmer Eye Institute, part of the University of Miami Health System.
Announced at the BIO International Convention 2026 in San Diego, USA, the partnership aims to establish the Middle East's first Eye Bank in Abu Dhabi, creating a critical new healthcare capability that will transform access to sight-restoring corneal transplantation across the UAE and wider region.
-
Abu Dhabi Biobank and Bascom Palmer Eye Institute partner to launch the Middle East’s first Eye Bank, based in Abu Dhabi.
-
The facility will reduce reliance on imported donor corneal tissue and build long-term regional transplant capability.
-
Bascom Palmer Eye Institute, ranked America’s best eye hospital 24 times by U.S. News & World Report, will support clinical protocols, training and research for the new eye bank.
